Today's Date: March 28, 2024
Leidos Partnership deploys electronic health record system to joint DOD-VA federal health care site   •   Mark Cuban Backs Overplay, the No-Code Game Creation Platform, Following Shark Tank Appearance   •   Chris Diehl Returns to 101 Mobility as Director of National Accounts   •   Sprinklr Appoints Amitabh Misra as Chief Technology Officer   •   Fox Lake Grade School District 114 Selects Varsity Tutors for Schools to Provide Students with Additional Learning Resources   •   Lightshift Energy Raises $100 Million From Greenbacker Capital Management to Expand Utility Scale Battery Storage Across North A   •   Philip Morris International Demonstrates Clear Progress Toward Its Purpose as It Releases 2023 Integrated Report   •   Avnos and Deep Sky Forge Path to Gigaton-Scale Carbon Removal in Canada   •   United Makes It Easier for Customers Who Use Wheelchairs to Book Flights That Can Accommodate Their Personal Device   •   Cadence OTC Announces Community Investment Campaign to Support the Movement for Accessible Birth Control in Post-Roe America   •   PRIVATE SCHOOL VILLAGE (PSV) AWARDS INAUGURAL ELEMENTARY-SCHOOL SCHOLARSHIPS   •   CYNTHIA BAILEY PARTNERS WITH KINDRA TO RAISE AWARENESS ABOUT VAGINAL HEALTH DURING MENOPAUSE   •   Lenzing strives to drive beneficial transformation across the value chain   •   The Home Depot Announces Agreement to Acquire SRS Distribution, a Leading Specialty Trade Distributor Across Multiple Verticals;   •   SunCoke Energy, Inc. Issues 2023 Sustainability Report   •   Cardinal Tobin Blesses New Open-Air Mausoleum of the Holy Spirit Site   •   HCA Healthcare Releases 2024 Annual Impact Report   •   ¡BUENA! 'LOTERÍA FANTÁSTICA' BRINGS THE FIESTA WITH WORLDWINNER'S FIRST-EVER BILINGUAL GAME   •   SolarEdge Launches SolarEdge ONE Optimization Solution for Homeowners with a Dynamic Rate Plan in the Netherlands   •   Zuniga Health's 'Elevate' health plans fit the needs for Hispanic small businesses
Bookmark and Share

Bristol Myers Squibb to Participate in the Guggenheim Healthcare Talks 2023 Oncology Conference

NEW YORK , February 03 /Businesswire/ - Bristol Myers Squibb (NYSE: BMY) today announced that the company will take part in a fireside chat at the Guggenheim Healthcare Talks 2023 Oncology Conference on Thursday, February 9, 2023. Chris Boerner, Ph.D., Executive Vice President, Chief Commercialization Officer, will answer questions about the company at 1:00 p.m. ET.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

corporatefinancial-news


STORY TAGS: Conference, Webcast, United States, North America, Biotechnology, Pharmaceutical, Health, Oncology, New York,

Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News